Staff
Articles
Continuing Education: June 2021
June 22, 2021
Article
CE lesson worth 1 contact hour that is intended to advanced practice nurses, registered nurses, and other healthcare professionals who care for patients with cancer.
Three Tenets to Prevent Stivarga-Related Side Effects, Improve Survival and Quality of Life
May 28, 2021
Article
Although Stivarga may cause side effects after initial treatment, a dose escalation strategy and the preemptive use of steroid creams may help patients to tolerate the regimen better, while allowing them to capitalize on the agent’s survival benefit.
Continuing Education: April 2021
April 22, 2021
Article
CE lesson worth 1 contact hour that is intended to advanced practice nurses, registered nurses, and other healthcare professionals who care for patients with cancer.
Clinical Insights: December 2020
December 22, 2020
Article
CE lesson worth 1 contact hour that is intended to advanced practice nurses, registered nurses, and other healthcare professionals who care for patients with cancer.
Clinical Insights: October 2020
October 22, 2020
Article
CE lesson worth 1 contact hour that is intended to advanced practice nurses, registered nurses, and other healthcare professionals who care for patients with cancer.
HER2-targeted Therapy: Routes of Administration
October 03, 2020
Video
Evaluating the benefits of the subQ vs IV formulation of the trastuzumab-pertuzumab combination for the management of HER2+ breast cancer and examining the potential use of at-home administration.
Clinical Insights: August 2020
September 03, 2020
Article
CE lesson worth 1 contact hour that is intended to advanced practice nurses, registered nurses, and other healthcare professionals who care for patients with cancer.
FDA Approves Pembrolizumab for Cutaneous Squamous Cell Carcinoma
June 24, 2020
Article
The FDA has approved pembrolizumab (Keytruda) or patients with recurrent or metastatic cutaneous squamous cell carcinoma that is not curable by surgery or radiation.